JuvRX Green Cells Background


Therapies that target aging and age-related disease.

Our focus is on traditional prescription medicines to modify aging and prevent diseases.
JuvRx Petri Dish

About RX

We see profound scientific advances in the area of healthy aging and longevity. Our goal is to help individuals reimagine their short and long-term health. We’re also positioned to impact the greater healthcare system, as it reinvents how to serve patients, confronting the diseases related to aging. With a team of world class drug developers, we’re targeting the fundamental molecular, cellular and tissue pathways of aging. We identify pharmacotherapies of great potential and manage their development to maximize the chance and speed of regulatory approval.

In the News


Extension of NetraMark’s NetraPharma Collaboration with Juvenescence

NetraMark Corp. and Juvenescence are excited to announce the extension of their collaboration agreement to include drug repurposing and drug discovery.

December 10, 2019

Read More

Juvenescence Capitalizes BYOMass

Juvenescence is pleased to announce its latest equity investment in BYOMass, a Massachusetts-based company focused on central control of metabolism in the context of aging and age-related diseases.

March 27, 2019

Read More
Contact Us
We are here to help answer any questions you might have.